[1]
N. A. Shah, S. Paul, S. Parveen, M. H. Bhat, I. Ali, and S. A. Kadla, “Therapeutic outcome of saroglitazar, a peroxisome proliferator activated receptor α/γ agonist in diabetic and non-diabetic metabolic dysfunction associated steatotic liver disease”, Int J Basic Clin Pharmacol, vol. 14, no. 4, pp. 519–525, Jun. 2025.